Overview

HKT-500-US12 In Adult Patients With OA Knee Pain

Status:
Completed

Trial end date:
2008-08-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to characterize the analgesic properties of single dose study of HKT-500 in subjects with pain caused by mild to moderate OA of the knee

Phase:

Phase 2

Details

Lead Sponsor:

Hisamitsu Pharmaceutical Co., Inc.

Treatments:

Analgesics
Ketoprofen